In addition, ART enhanced LC3A-LC3B conversion and SQSTM1/p62 accumulation, as evidenced by the increasing number of LC3B puncta in HCC cells, and these effects were further enhanced by the addition of the late-stage autophagy inhibitor BAF. The gene discussed is MAP1LC3A; the disease is hepatocellular carcinoma.